I can agree with that , with a few questions. I
Post# of 22454
Quote:
I’m seeing things differently. To me the Distribution Agreement, which includes the minimum guaranteed revenues and the integrated product milestone, is setup as a parallel path, not in series with the Equity Investment purchases and milestones.
Innova already has a distribution agreement in place with QMC, going forward should we treat Pasaca agreement separate from the Innova agreement, a replacement or the Innova agreement, or an add on to the Innova agreement?
Quote:
“We are confident that adding QDX HealthID Incorporated to Innova Medical Group’s rapid test kit distribution group will ensure that even more, superior testing solutions will continue being a key solution for effectively detecting and tracking the COVID-19 virus, worldwide,” shares Dr. Charles Huang, Founder and Partner of Pasaca Capital Inc.
If QMC fails to develop a functional product that works with the Innova products does Pasaca Capital still purchase 51% of QMC?